Catheters, Vascular, Angioplasty, Balloon, Coronary, Drug Delivery

Definition : Balloon angioplasty catheters designed for percutaneous transluminal coronary angioplasty that are capable of local delivery of drugs either before, during, or after dilatation of the lesion. These catheters may deliver the drugs using a variety of techniques, including: (1) porous balloons with laser-drilled holes to deliver the drugs; (2) two-balloon devices that isolate the segment of the lesion permitting its filling with the drug; (3) injection of nanoparticles loaded with the drug; and (4) use of drug-coated balloons (also known as drug-eluting balloons). Drug delivery coronary balloon catheters are used for local administration of concentrated drugs directly to the site of arterial injury during coronary angioplasty procedures.

Entry Terms : "Drug Delivery Catheters" , "Porous Balloon Drug Delivery Catheters" , "Catheters, Perfusion" , "Infusion Catheters" , "Catheters, Vascular, Angioplasty, Balloon, Coronary Infusion" , "Coronary Angioplasty Drug Delivery Balloon Catheters" , "Drug Delivery Balloon Coronary Angioplasty Catheters" , "Drug-Coated Balloon Catheters, Coronary" , "Drug-Coated Balloons" , "Drug-Eluting Balloon (DEB) Catheters, Coronary"

UMDC code : 18645

U.S.companies only
Suppress Subsidiary Companies

1-5 of 5 Match(es).

Boston Scientific Corp

Company Type: Parent

In 1969, fascinated by the possibility of bringing pioneering medical devices and treatments to patients across the world, John Abele joined Medi-Tech, a company that was developing alternatives to traditional surgery. Pete Nicholas was looking for an investment, and when he met John, the pieces came together.


Company Type: Parent

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005.

Endologix Inc

Company Type: Parent

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA.

InSitu Technologies Inc

Company Type: Parent

InSitu Technologies Inc. is a privately held medical device company specializing in intra-vascular stents and cardiovascular products. InSitu Technologies is dedicated to providing the world with a full portfolio of state-of-the-art minimally invasive products with a strong focus on the well being of our patients.

Medtronic Inc

Company Type: Parent

At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible.

1-5 of 5 Match(es).


Sign Up for Free e-newsletters

Medical Product Guide OBG Management Product Zone